Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on TAB. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel mild process for Capecitabine synthesis from Furtulon. High purity, scalable route offering significant cost reduction in pharmaceutical manufacturing.
Patent CN102993253B reveals a reusable polymer-supported catalyst method for synthesizing capecitabine intermediates, offering significant supply chain stability and cost reduction in pharmaceutical manufacturing.
Patent CN106191089B accelerates 5-AVA yield via transporter overexpression, offering cost-effective supply chain solutions for global pharmaceutical and chemical manufacturers.
Novel enzymatic route for 2-deoxy-2,2-difluoro-3,5-dibenzoyl-D-ribofuranose offers high yield and purity, replacing hazardous hydrogenation for reliable supply.
Patent CN103601777A details a high-purity capecitabine preparation method using isopropyl ether crystallization, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Novel patent CN102617678B offers high-purity Gemcitabine Hydrochloride synthesis with simplified steps and industrial scalability for reliable supply chain partners.
Patent CN112979723B details a novel Schiff base purification strategy for Gemcitabine intermediates, ensuring superior purity and yield for pharmaceutical manufacturing.
Patent CN104109182B details a safer gemcitabine hydrochloride synthesis route ensuring high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN101984066A reveals a high-yield biological method for L-phenylalanine production, reducing acetate inhibition and offering significant cost advantages for reliable amino acid suppliers.
Novel water-phase synthesis for Eltrombopag intermediate offers high purity and yield. Reduces solvent use and operational complexity for reliable pharmaceutical intermediate supply chains.
Novel synthesis of aggregation-induced luminescence nitroxide radicals via CN110818614A. Cost-effective route for fluorescent probes and OLED materials. Reliable supply chain partner.
Patent CN103254075B details a novel esterification route achieving ≥99.0% purity for injectable formulations, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Optimized three-step synthesis for Capecitabine API ensures high purity and industrial scalability for global pharmaceutical supply chains and cost reduction.
Novel patent CN102010455A details a high-purity Decitabine route avoiding isomer separation. Ideal for cost reduction in API intermediate manufacturing.
Patent CN108358803B reveals cost-effective deuteration method enhancing supply chain reliability and purity for pharmaceutical intermediate manufacturing globally.
Patent CN103664754B reveals a safer Grignard route for Etoricoxib intermediates. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical compounds.
Patent CN102382160B details a green capecitabine route using manganese chloride. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102010455B reveals a novel Decitabine synthesis avoiding isomer separation. High purity >99.85% via Barton-McCombie deoxygenation for cost-effective manufacturing.
Advanced total synthesis of 13C7-patulin via patent CN113004300A. High purity isotope standards for precise mass spectrometry quantification in agrochemical and food testing.
Patent CN106631991B details a safer, platinum-free synthesis route for hindered amine light stabilizer intermediates, offering significant cost and safety advantages.